Literature DB >> 2298742

Organic anion transport in macrophage membrane vesicles.

B J Lipman1, S C Silverstein, T H Steinberg.   

Abstract

Cells of the J774 mouse macrophage-like cell line possess organic anion transporter that transport fluorescent dyes such as Lucifer Yellow out of the cytoplasmic matrix of the cells; the dye is both sequestered in endosomes and secreted into the extracellular medium. Lucifer Yellow that is sequestered within endosomes is subsequently delivered to the lysosomal compartment. In the present studies we demonstrated that probenecid inhibited removal of Lucifer Yellow from the soluble cytoplasm and sequestration into membrane bound organelles by quantitating Lucifer Yellow fluorescence in both soluble and membrane-associated fractions of J774 cells. In addition, we examined the uptake of Lucifer Yellow into isolated subcellular organelles derived from J774 cells. Lucifer Yellow transport in the organellar fraction of J774 cell homogenates was temperature- and pH-dependent and did not require ATP. Subcellular organelles from J774 cells were fractionated into endosome- and lysosome-enriched fractions by Percoll density gradient centrifugation. Lucifer Yellow was preferentially taken up by vesicles of the endosome-enriched fraction, and this transport was inhibited by probenecid. These studies provide direct evidence that probenecid inhibits Lucifer Yellow transport out of the cytoplasmic matrix and into cytoplasmic vacuoles in J774 cells and that organic anion transport in isolated organelles derived from J774 cells occurs preferentially in endosome, rather than in lysosome-enriched fractions; they suggest that Lucifer Yellow is carried across membranes via a secondary active transport process that requires proton symptom or hydroxyl anion antiport.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298742

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Cellular retention of liposome-delivered anionic compounds modulated by a probenecid-sensitive anion transporter.

Authors:  Y K Oh; R M Straubinger
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

2.  Activation of neuronal NMDA receptors triggers transient ATP-mediated microglial process outgrowth.

Authors:  Lasse Dissing-Olesen; Jeffrey M LeDue; Ravi L Rungta; Jasmin K Hefendehl; Hyun B Choi; Brian A MacVicar
Journal:  J Neurosci       Date:  2014-08-06       Impact factor: 6.167

Review 3.  Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver.

Authors:  X Chu; K Korzekwa; R Elsby; K Fenner; A Galetin; Y Lai; P Matsson; A Moss; S Nagar; G R Rosania; J P F Bai; J W Polli; Y Sugiyama; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2013-04-10       Impact factor: 6.875

4.  Probenecid, a gout remedy, inhibits pannexin 1 channels.

Authors:  William Silverman; Silviu Locovei; Gerhard Dahl
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-02       Impact factor: 4.249

5.  Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system.

Authors:  T Nishida; Z Gatmaitan; M Che; I M Arias
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

6.  Inflammatory conditions induce gap junctional communication between rat Kupffer cells both in vivo and in vitro.

Authors:  Eliseo A Eugenín; Hernán E González; Helmuth A Sánchez; María C Brañes; Juan C Sáez
Journal:  Cell Immunol       Date:  2007-09-27       Impact factor: 4.868

7.  Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats.

Authors:  Lana J Mawhinney; Juan Pablo de Rivero Vaccari; Gordon A Dale; Robert W Keane; Helen M Bramlett
Journal:  BMC Neurosci       Date:  2011-12-01       Impact factor: 3.288

8.  Amplification of human platelet activation by surface pannexin-1 channels.

Authors:  K A Taylor; J R Wright; C Vial; R J Evans; M P Mahaut-Smith
Journal:  J Thromb Haemost       Date:  2014-06       Impact factor: 5.824

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.